## **Core Concept**
Antiglaucoma medications are used to reduce intraocular pressure (IOP) in patients with glaucoma. These medications work through various mechanisms, including decreasing aqueous humor production, increasing aqueous humor outflow, or reducing the resistance in the trabecular meshwork. Some of these medications can have systemic side effects due to their mechanism of action or absorption.

## **Why the Correct Answer is Right**
The correct answer, , is associated with the medication Brimonidine. Brimonidine is an alpha-2 adrenergic agonist used in the treatment of glaucoma to decrease intraocular pressure. One of its notable side effects is its ability to cross the blood-brain barrier, which can lead to central nervous system (CNS) effects, including drowsiness, fatigue, and in some cases, more severe CNS depression.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because is not commonly associated with causing drowsiness as a side effect in the context of antiglaucoma medications.
- **Option B:** - This option is incorrect because does not typically cause drowsiness; its side effects profile does not commonly include significant CNS depression.
- **Option D:** - This option is incorrect because is not typically known for causing drowsiness; its mechanism of action does not commonly result in CNS effects like drowsiness.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Brimonidine, an alpha-2 adrenergic agonist, can cause CNS effects, including drowsiness, due to its ability to cross the blood-brain barrier. This is a critical consideration, especially in pediatric patients and the elderly, who may be more susceptible to these effects.

## **Correct Answer:** . Brimonidine.